Quantcast

How bakers really create the unique patterns on the top of bread loaves

Mesmerising 'behind the scenes' video reveals the incredible technique bakers use to create the patterns on top of bread loaves A baker has shared video...
More

    ‘War of the Roses’ brawler Brandon Locke-Walker banned from drinking alcohol after Rosehill brawl

    'War of the Roses' brawler seen fighting with up to 30 people at Rosehill Racecourse is banned from drinking for a YEAR but avoids...

    Simone Holtznagel shows off ample assets on wild night out

    Model Simone Holtznagel shows off her ample assets in a VERY plunging dress as she laughs it up with Abbie Chatfield on a wild...

    Pro-surfer sisters Ellie-Jean Coffey and Holly-Daze Coffey offer explicit OnlyFans style content

    Surfer sisters Ellie-Jean Coffey and Holly-Daze Coffey offer explicit OnlyFans-style content as they launch their 'uncensored' paid websites By Marta Jary For Daily Mail Australia...

    Only Native American on federal death row is executed for killing nine-year-old girl and grandmother

    Only Native American on federal death row is executed after 19 years for killing nine-year-old girl and her grandmother in 2001 and says 'No,...

    Astra seals deal to mass produce its Covid jab, as it begins US trials

    Astra seals deal to mass produce its Covid jab, as it begins large-scale human trials in the US

    Astrazeneca has struck a deal to mass-produce a potential Covid-19 vaccine, as it begins large-scale human trials in the US.

    The FTSE 100 drugs firm will pay gene therapy group Oxford Biomedica £15million up front to scale up manufacturing capacity of the vaccine, as it hopes to win fast-track approval in the US, and plans to enrol up to 30,000 test candidates.

    Astrazeneca’s shot, developed in collaboration with researchers at Oxford University, is one of the most promising vaccinations under way. 

    Vaccine deal: Astrazeneca will pay gene therapy group Oxford Biomedica £15m up front to scale up manufacturing capacity of the vaccine

    Experts hope it will halt the spread of coronavirus, which has already killed more than 850,000 people.

    A final-stage trial is in progress in the UK, and reports have emerged that the US may be aiming for approval before the November presidential election.

    Astrazeneca’s chief executive Pascal Soriot said: ‘We are moving quickly but without cutting corners, and regulators have clear and stringent efficacy and safety standards for the approval of any new medicine, and that includes this potential Covid-19 vaccine.’

    Oxford Biomedica said it expected to receive more than £35million more if the vaccine was successful, as it manufactures large batches of the vaccine until the end of 2021.

    Already the UK has bought 100m doses of the vaccines, while the European Union has bought 300m. Astrazeneca shares fell 1.7 per cent, or 143p, to 8197p.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Posts

    Ten-inch amphibians go to war in amazing battle 

    It's a bull (frog) fight! Ten-inch amphibians go to war in amazing battle Male bullfrogs caught battling for females in a rare spectacle in South...

    Alexander Povetkin ‘will seek WBC mandatory fight with Tyson Fury’ with win over Dillian Whyte

    Alexander Povetkin 'will seek WBC mandatory fight with Tyson Fury' with another win over Dillian Whyte and '81,000-seater Luzhniki Stadium could play host', reveals...

    How bakers really create the unique patterns on the top of bread loaves

    Mesmerising 'behind the scenes' video reveals the incredible technique bakers use to create the patterns on top of bread loaves A baker has shared video...

    Katie Holmes’ new beau Emilio Vitolo Jr. matches his white shirt with his driving cap while shopping

    Katie Holmes' new chef boyfriend Emilio Vitolo Jr. matches his white shirt with his driving cap as he stocks up on essentials in New...